Search Results - "Armistead, D"

Refine Results
  1. 1

    Characterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cells by Iwata, Yohei, Matsushita, Takashi, Horikawa, Mayuka, DiLillo, David J., Yanaba, Koichi, Venturi, Guglielmo M., Szabolcs, Paul M., Bernstein, Steven H., Magro, Cynthia M., Williams, Armistead D., Hall, Russell P., St Clair, E. William, Tedder, Thomas F.

    Published in Blood (13-01-2011)
    “…Regulatory B cells control inflammation and autoimmunity in mice, including the recently identified IL-10–competent B10 cell subset that represents 1% to 3% of…”
    Get full text
    Journal Article
  2. 2

    Differential expression of miRNAs in the visceral adipose tissue of patients with non‐alcoholic fatty liver disease by Estep, M., Armistead, D., Hossain, N., Elarainy, H., Goodman, Z., Baranova, A., Chandhoke, V., Younossi, Z. M.

    Published in Alimentary pharmacology & therapeutics (01-08-2010)
    “…Aliment Pharmacol Ther 2010; 32: 487–497 Summary Background  Progression of non‐alcoholic fatty liver disease (NAFLD) can be facilitated by soluble molecules…”
    Get full text
    Journal Article
  3. 3

    A Nonimmunosuppressant FKBP-12 Ligand Increases Nerve Regeneration by Gold, Bruce G., Zeleny-Pooley, Michelle, Wang, Min-Sheng, Chaturvedi, Pravin, Armistead, David M.

    Published in Experimental neurology (01-10-1997)
    “…The immunosuppressant drugs FK506 and cyclosporin A inhibit T-cell proliferation via a common mechanism: calcineurin inhibition following binding to their…”
    Get full text
    Journal Article
  4. 4
  5. 5

    A Novel Immunophilin Ligand: Distinct Branching Effects on Dopaminergic Neurons in Culture and Neurotrophic Actions after Oral Administration in an Animal Model of Parkinson's Disease by Costantini, L.C., Chaturvedi, P., Armistead, D.M., McCaffrey, P.G., Deacon, T.W., Isacson, O.

    Published in Neurobiology of disease (01-08-1998)
    “…Protection or regeneration of the dopaminergic (DA) system would be of significant therapeutic value for Parkinson's disease. Immunophilin ligands, such as…”
    Get full text
    Journal Article
  6. 6

    SCHOOL PSYCHOLOGISTS' CONTINUING PROFESSIONAL DEVELOPMENT PREFERENCES AND PRACTICES by Armistead, Leigh D., Castillo, Jose M., Curtis, Michael J., Chappel, Ashley, Cunningham, Jennifer

    Published in Psychology in the schools (01-04-2013)
    “…This study investigated school psychologists’ continuing professional development (CPD) activities, topics, needs, motivations, financial expenditures, and…”
    Get full text
    Journal Article
  7. 7

    Quantitative NAT for pathogen inactivation verification by McKenney, K, Gillmeister, L, Marlowe, K, Armistead, D, Burgess, W, Drohan, W

    Published in Developments in biologicals (2004)
    “…A novel Quantitative Nucleic Acid Test (Q-NAT) technology has been developed to demonstrate, quantify and verify pathogen inactivation by methods that break…”
    Get more information
    Journal Article
  8. 8

    Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro by Germann, U A, Shlyakhter, D, Mason, V S, Zelle, R E, Duffy, J P, Galullo, V, Armistead, D M, Saunders, J O, Boger, J, Harding, M W

    Published in Anti-cancer drugs (01-02-1997)
    “…VX-710 or (S)-N[2-Oxo-2-(3,4,5-trimethoxyphenyl)acetyl]-piperidine-2-carboxylic acid 1,7-bis(3-pyridyl)-4-heptyl ester, a novel non-macrocyclic ligand of the…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Control region mutations and the 'common deletion' are frequent in the mitochondrial DNA of patients with esophageal squamous cell carcinoma by Abnet, Christian C, Huppi, Konrad, Carrera, Ana, Armistead, David, McKenney, Keith, Hu, Nan, Tang, Ze-Zong, Taylor, Philip R, Dawsey, Sanford M

    Published in BMC cancer (01-07-2004)
    “…North central China has some of the highest rates of esophageal squamous cell carcinoma in the world with cumulative mortality surpassing 20%. Mitochondrial…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Heparin-independent mitogenicity in an endothelial and smooth muscle cell chimeric growth factor (S130K-HBGAM) by Brewster, Luke P., Brey, Eric M., Tassiopoulos, Apostolos K., Xue, Lian, Maddox, Ewa, Armistead, David, Burgess, Wilson H., Greisler, Howard P.

    Published in The American journal of surgery (01-11-2004)
    “…Through site-directed mutagenesis we have created a favorable fibroblast growth factor-1 (FGF-1) mutant (S130K) and linked it to a heparin-binding…”
    Get full text
    Journal Article Conference Proceeding
  18. 18
  19. 19

    Platinum coil-mediated implantation of growth factor-secreting endovascular tissue grafts: an in vivo study by Kallmes, D F, Williams, A D, Cloft, H J, Lopes, M B, Hankins, G R, Helm, G A

    Published in Radiology (01-05-1998)
    “…To demonstrate in vivo that platinum embolic coils can be used to deliver genetically modified, growth factor-secreting fibroblast grafts into the endovascular…”
    Get more information
    Journal Article
  20. 20